Literature DB >> 25948850

A mitotic cause of Whipple's triad: non-islet cell tumour hypoglycaemia in incurable low-grade malignancy.

Angela S Lee1, Stephen M Twigg1.   

Abstract

A 74-year-old man with known metastatic haemangiopericytoma presented with neuroglycopaenic symptoms of confusion and light-headedness secondary to recurrent episodes of fasting hypoglycaemia, which resolved with oral carbohydrate intake. Investigations for hypoglycaemia revealed it to be non-insulin mediated, and subsequently due to a rare paraneoplastic phenomenon termed as non-islet cell tumour hypoglycaemia caused by tumoural overproduction of high molecular weight insulin-like growth factor-II. Despite his underlying malignancy being incurable, directed multimodality treatment involving regular oral carbohydrate intake, glucocorticoid therapy and recombinant human growth hormone was effective in relieving symptoms of hypoglycaemia. We discuss the importance of a systematic diagnostic approach to hypoglycaemia fulfilling Whipple's triad, as specific therapies can be invaluable to improving quality of life. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25948850      PMCID: PMC4434322          DOI: 10.1136/bcr-2014-209021

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Treatment of hemangiopericytoma-induced hypoglycemia with growth hormone and corticosteroids.

Authors:  D Gullo; L Sciacca; G Parrinello; L Tomaselli; R Vigneri
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

2.  Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.

Authors:  Nathalie Bourcigaux; Gwenaëlle Arnault-Ouary; Rémy Christol; Laurence Périn; Bernard Charbonnel; Yves Le Bouc
Journal:  Clin Ther       Date:  2005-02       Impact factor: 3.393

3.  Hepatic and pulmonary metastases from a meningeal hemangiopericytoma and severe hypoglycemia due to abnormal secretion of insulin-like growth factor: a case report.

Authors:  F Grunenberger; P Bachellier; M P Chenard; G Massard; P L Caraman; E Perrin; J Zapf; D Jaeck; J L Schlienger
Journal:  Cancer       Date:  1999-05-15       Impact factor: 6.860

Review 4.  The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia.

Authors:  R C Baxter
Journal:  Horm Res       Date:  1996

Review 5.  Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive.

Authors:  Yevgeniya Dynkevich; Kristina I Rother; Ian Whitford; Sana Qureshi; Sneha Galiveeti; Alessandra L Szulc; Ann Danoff; Tracy L Breen; Nargess Kaviani; Michael H Shanik; Derek Leroith; Riccardo Vigneri; Christian A Koch; Jesse Roth
Journal:  Endocr Rev       Date:  2013-05-13       Impact factor: 19.871

6.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.

Authors:  Philip E Cryer; Lloyd Axelrod; Ashley B Grossman; Simon R Heller; Victor M Montori; Elizabeth R Seaquist; F John Service
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

Review 7.  Management of non-islet-cell tumor hypoglycemia: a clinical review.

Authors:  Timothy W Bodnar; Maria J Acevedo; Massimo Pietropaolo
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

Review 8.  Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases.

Authors:  Jan Willem B de Groot; Bart Rikhof; Jaap van Doorn; Henk J G Bilo; Maarten A Alleman; Aafke H Honkoop; Winette T A van der Graaf
Journal:  Endocr Relat Cancer       Date:  2007-12       Impact factor: 5.678

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.